Tag: Angle closure

Globally, an estimated 13% of myopia control treatments involve atropine [1.3.2]. A primary concern for clinicians and patients is the question: **does topical atropine increase intraocular pressure (IOP)**, and what are the associated risks?

Studies show that amitriptyline, a tricyclic antidepressant, carries a documented risk of causing or worsening angle-closure glaucoma in some individuals due to its anticholinergic properties. This serious, yet rare, side effect can lead to permanent vision loss if not addressed promptly.